BIMO KAPITAL
BIMO KAPITAL
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-24 | Hoylu | Bimo Kapital investment in Post-IPO Debt - Hoylu | 15 M SEK |
More informations about "Bimo Kapital"
BIMO KAPITAL AS - Information on organisations - The …
Information on organisations from The Brønnøysund Register Centre. Register search Limited company Register, change, close Sole proprietorship Register, change, close Clubs and …See details»
Bimo Kapital - Crunchbase Investor Profile & Investments
Bimo Kapital is an investment firm. Lists Featuring This Company. Edit Lists Featuring This Company Section. Scandinavia Investors . 2,163 Number of Organizations • $83B Total …See details»
Transparency Act Due Diligence Report - eltekholding.com
People within our organization, subsidiaries, and value chain s. In line with the principles of the Norwegian Transparency Act, we are committed to conducting comprehensive due diligence …See details»
Bimo Kapital - Investments, Portfolio & Company Exits - Crunchbase
Jan 24, 2022 Bimo Kapital has had . obfuscated. obfuscated. exit, which was Hoylu. Which industries has this organization had the most exits in? Show . Hoylu Hoylu is delivers solutions …See details»
Bimo Kapital AS Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Bimo Kapital AS of OSLO, OSLO. Get the latest business insights from Dun & Bradstreet.See details»
Bimo Kapital - CB Insights
Jun 26, 2024 Bimo Kapital has made 2 investments. Their latest investment was in Hoylu as part of their PIPE on March 01, 2021. Bimo Kapital Investments Activity. View Investments Chart. …See details»
BIMO KAPITAL AS - Norway - globalfinreg.com
Sep 15, 2024 BIMO KAPITAL AS is an active company registered in Norway. It is identified by the legal entity identifier (LEI) 254900KMHE9SXO9NP537. The LEI is a unique code used …See details»
BIMO KAPITAL AS · Postboks 1618 Vika, Oslo, NO-03, 0119, NO
BIMO KAPITAL AS (LEI# 254900KMHE9SXO9NP537) is a legal entity registered with Bloomberg Finance L.P.. The address is Postboks 1618 Vika, Oslo, NO-03, 0119, NO. Toggle navigation …See details»
Bimo Kapital (investor) - Nordic 9
Bimo Kapital is an investment company owned by Morten F. Angelil. Average round investment: 8.5M USD. Average number per year: 1.0. Distribution: 2015 (1) Portfolio companies: …See details»
BIMO KAPITAL AS (LEI 254900KMHE9SXO9NP537)
LEI number of BIMO KAPITAL AS (254900KMHE9SXO9NP537). Information about company legal address, registration details and jurisdiction.See details»
LEI:
BIMO KAPITAL AS. Language Code. no. Legal Address (English) Dronning Maudsgate 15, PB 1618 Vika Oslo, Oslo (NO-03), 0250 NORWAY. Headquarters Address (English) Postboks …See details»
Bimo Kapital - Updates, News, Events, Signals & Triggers
Bimo Kapital is an investment firm. Start Free Trial . Chrome ExtensionSee details»
Pixotope Technologies AS - Detailed information
Business ID: 812 664 522 Company: Pixotope Technologies AS Address:See details»
About BMO | BMO Financial Group - BMO Canada
At BMO, we’re trusted advisors, leaders in our communities and backers of opportunities that transform a continent. Let’s help you reach your financial goals.See details»
Bimo Kapital - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Bimo Kapital is an investment firm. Start Free Trial . Chrome ExtensionSee details»
Australian Firefighters Wall Calendar 2025 - Real ... - Pinterest
About this item Disclosure: "Date matches day of the week on the top. End of the month may be on the top left" Daily Organization: You’ll never be more motivated to stay organized with a …See details»
Beware of BIMO: Complete Response Letter, Warning Letter and
3 days ago FDA proceeded to conduct a routine preapproval BIMO inspection that concluded in May 2024, and reviewed Applied Therapeutics’ AT-007-1002 trial (NCT 04902781, the …See details»
Complete Response Letter, Warning Letter and Shareholder …
1 day ago FDA proceeded to conduct a routine preapproval BIMO inspection that concluded in May 2024, and reviewed Applied Therapeutics’ AT-007-1002 trial (NCT 04902781, the …See details»
Hoylu - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 24, 2022: Post-IPO Debt - …See details»
Beware of BIMO: Complete Response Letter, Warning Letter and ...
2 days ago Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter 1 from the US …See details»